Dosimetry of transmission measurements in nuclear medicine: a study using anthropomorphic phantoms and thermoluminescent dosimeters

Abstract. Quantification in positron emission tomography (PET) and single photon emission tomographic (SPET) relies on attenuation correction which is generally obtained with an additional transmission measurement. Therefore, the evaluation of the radiation doses received by patients needs to include the contribution of transmission procedures in SPET (SPET-TM) and PET (PET-TM). In this work we have measured these doses for both PET-TM and SPET-TM. PET-TM was performed on an ECAT EXACT HR+ (CTI/Siemens) equipped with three rod sources of germanium-68 (380 MBq total) and extended septa. SPET-TM was performed on a DST (SMV) equipped with two collimated line sources of gadolinium-153 (4 GBq total). Two anthropomorphic phantoms representing a human head and a human torso, were used to estimate the doses absorbed in typical cardiac and brain transmission studies. Measurements were made with thermoluminescent dosimeters (TLDs, consisting of lithium fluoride) having characteristics suitable for dosimetry investigations in nuclear medicine. Sets of TLDs were placed inside small plastic bags and then attached to different organs of the phantoms (at least two TLDs were assigned to a given organ). Before and after irradiation the TLDs were placed in a 2.5-cm-thick lead container to prevent exposure from occasional sources. Ambient radiation was monitored and taken into account in calculations. Transmission scans were performed for more than 12 h in each case to decrease statistical noise fluctuations. The doses absorbed by each organ were calculated by averaging the values obtained for each corresponding TLD. These values were used to evaluate the effective dose (ED) following guidelines described in ICRP report number 60. The estimated ED values for cardiac acquisitions were 7.7×10–4±0.4×10–4 mSv/MBq · h and 1.9×10–6±0.4×10–6 ███/MBq · h for PET-TM and SPET-TM. respectively. For brain scans, the values of ED were calculated as 2.7×10–4±0.2×10–4 mSv/MBq · h for PET-TM and 5.2×10–7±2.3×10–7 mSv/MBq · h for SPET-TM. In our institution, PET-TM is usually performed for 15 min prior to emission. SPET-TM is performed simultaneously with emission and usually lasts 30 and 15 min for brain and cardiac acquisitions respectively. Under these conditions ED values, estimated for typical source activities at delivery time (22000 MBq in SPET and 555 MBq for PET), were 1.1×10–1± 0.1×10–1 mSv and 1.1×10–2±0.2×10–2 mSv for cardiac PET-TM and SPET-TM respectively. For brain acquisitions, the ED values obtained under the same conditions were 3.7×10–2±0.3×10–2 mSv and 5.8×10–3±2.6×10–3███ for PET-TM and SPET-TM respectively. These measurements show that the dose received by a patient during a transmission scan adds little to the typical dose received in a routine nuclear medicine procedure. Radiation dose, therefore, does not represent a limit to the generalised use of transmission measurements in clinical SPET or PET.

[1]  H. Kung,et al.  Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  F S Prato,et al.  Transmission computed tomography imaging of the head with a SPECT system and a collimated line source. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  S R Cherry,et al.  Attenuation correction using count-limited transmission data in positron emission tomography. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  S. McKeever,et al.  Thermoluminescence Dosimetry Materials: Properties and Uses , 1995 .

[5]  H. Watabe,et al.  Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radiopharmaceuticals. , 1991, Journal of radiation research.

[6]  D. Berman,et al.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  B. Tsui,et al.  Performance characteristics of transmission imaging using a uniform sheet source with parallel-hole collimation. , 1992, Medical physics.

[8]  J Hashimoto,et al.  Scatter and attenuation correction in technetium-99m brain SPECT. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R. Cloutier Tissue Substitutes in Radiation Dosimetry and Measurement. , 1989 .

[10]  D. Sutton,et al.  Optimization and deconvolution of lithium fluoride TLD-100 in diagnostic radiology. , 1997, The British journal of radiology.

[11]  E. Länsimies,et al.  The dosimetry of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane. , 1994, European journal of nuclear medicine.

[12]  B F Hutton,et al.  A scanning line source for simultaneous emission and transmission measurements in SPECT. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  B. Bendriem,et al.  Bone equivalent liquid solution to assess accuracy of transmission measurements in SPECT and PET , 1996, 1996 IEEE Nuclear Science Symposium. Conference Record.